BOULDER, Colo., July 21, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (the €œCompany€ or €œFresh Tracks€) (Nasdaq: FRTX), a clinical-stage pharmaceutical company striving to transform...
BERWYN, Pa. – Troutman Pepper client Botanix Pharmaceuticals Limited (ASX: BOT), a clinical dermatology company, has announced the acquisition of Sofpironium Bromide gel, 15%, from Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company. The gel was developed to treat primary axillary hyperhidrosis, a medical condition that results in excessive underarm sweating. Read a company press release about the acquisition.
PHILADELPHIA & SYDNEY--(BUSINESS WIRE)--Clinical stage synthetic cannabinoid company Botanix Pharmaceuticals Limited has today published positive data from a world first human clinical study, examining the safety, tolerability and efficacy of its BTX 1801 antimicrobial product for the eradication of Staphylococcus Aureus (Staph).